@PlayBookTrades MuseCell (Singapore) hired Celularity's Florham Park plant to make stem cells.
MuseCell might spend $300M there over 5 years if setup works.
That's their estimate. Not a purchase order.
@PlayBookTrades $WNW is a skincare company who announced they're building an AI app.
Not a profitable business. FY25 loss $18.6M on $7.1M sales.
On Aug 20, 2026, they signed to buy 100% of Xiamen Hemeitong for ¥235.2M (~$35M). 6-K published 8/26/26.
It hasn't closed. It's not a done deal.
@JasperRidley Tue Aug 25 - Edwin Roks, CEO - bought $1.12M
Tue Aug 25 - Daniel Boehle, CFO - withheld $661k
Mon Aug 24 - Rex Geveden, director - bought $525k
Mon Aug 10 - Dale Knecht, SVP - sold $3.72M
Thu Jun 25 - Daniel Boehle, CFO - sold $881k
Thu Jun 25 - Shawn Powers, EVP - sold $704k
@greatstockpicks 74 Relative Volume hits today on our scanners.
For comparison, the last time the RVOL scanner fired for $SOAR was on August 10th with 15 A+ hits.
$NVDA
Rev $96.2B vs $91B guidance and $92.2B the street.
+18% Q/Q, +106% Y/Y. Data Center $89.0B, +117% Y/Y. GM 75%.
Q3 they want $108B ±2%. GM ~74%, down a point. Still no China DC compute in the outlook.
@StockSavvyShay@Fiscal_ai $LULU biggest drawdown in 20 years was in 2009.
−92%. $29 → $2.25.
This is −77% from $511. Second place.
The catalyst for this drop is that the North American market is shrinking Q1 -3%.
China +30% on 19% of Q1 sales. Rest of world also +13%.
@TheValueTrade Gross profit $3.8M, down 71% from last year. Implied Q2 even lost money before opex.
Margin 34.2% → 4.9%.
They reported yesterday after the close.
@epictrades1 It led last Wednesday through Friday. +24%, then +9% with $QQQ red, then +9% again.
Yesterday was the down day, -9%. Today it's back up 5%.
@SuperDuperInvst They're not in compliance. They're at risk of being delisted.
22.8M common shares as of Aug 13.
Another 3.11M converted into common on Aug 17.
Board voted to do 1-for-5 to 1-for-50 anytime in the next 12 months.
They will likely reverse before or around Sep 15.
@Gubloinvestor $RPRX put $250 million into a part of Ziihera royalties through Zymeworks
It gets 30% of Zymeworks’ royalty on those sales until it has collected about 1.65× the note (~$413 million) by 2033, or 1.925× after that.
$413M is about 1.5% of their $27.3B market cap.
@stockplaymaker1 CEO owns 1,386,624 common shares after Friday’s 8/21/26 buy (0.22% of 617.6M).
$5.73M is 2025 compensation package. $4.04M of it is stock awards, salary $457k, bonus $1.15M, other $76k.
@mind1nvestor $DLO has not closed above $20 since Sep 18, 2023. 52-week high is $16.78.
General Atlantic sold 9.8M Class A last Monday at $13.60. Still holds 21%